FDA Drugs (New Approvals & NDA)Original article
Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg /ml) Single-Dose Infusion Bag in 100ml Due to Particulate Matter Found in Solution
RegulatoryCefazolin in Dextrose Injection, USP, 2G / 100mlNegative
AI Analysis
Summary
Baxter International voluntarily recalled Lot LD175708 of Cefazolin in Dextrose Injection due to particulate matter (cardboard) identified in the solution. The recall affects a single lot with expiration date February 14, 2027.
Outcome Details
Voluntary nationwide recall of Lot LD175708 due to particulate matter (cardboard) found in solution
Importance:4/10
Sentiment:
-0.80
product recallquality issuepharmaceutical manufacturingpatient safetyinjectable medication
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 8, 2026 12:55 AM